183 related articles for article (PubMed ID: 10875097)
1. Evaluation of a strategy to limit blood donor exposure in high risk premature newborns based on clinical estimation of transfusion need.
van Straaten HL; de Wildt-Eggen J; Huisveld IA
J Perinat Med; 2000; 28(2):122-8. PubMed ID: 10875097
[TBL] [Abstract][Full Text] [Related]
2. [Effect of age of erythrocyte concentration administered to premature infants: a retrospective study].
Andriessen P; Kollée LA; van Dijk BA
Tijdschr Kindergeneeskd; 1993 Jun; 61(3):82-7. PubMed ID: 8211940
[TBL] [Abstract][Full Text] [Related]
3. Transfusions of CPDA-1 red blood cells stored for up to 28 days decrease donor exposures in very low-birth-weight premature infants.
Fernandes da Cunha DH; Nunes Dos Santos AM; Kopelman BI; Areco KN; Guinsburg R; de Araújo Peres C; Chiba AK; Kuwano ST; Terzian CC; Bordin JO
Transfus Med; 2005 Dec; 15(6):467-73. PubMed ID: 16359417
[TBL] [Abstract][Full Text] [Related]
4. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
[TBL] [Abstract][Full Text] [Related]
5. Strict guideline reduces the need for RBC transfusions in premature infants.
Venâncio JP; Santos AM; Guinsburg R; Peres Cde A; Shinzato AR; Lora MI
J Trop Pediatr; 2007 Apr; 53(2):78-82. PubMed ID: 17166932
[TBL] [Abstract][Full Text] [Related]
6. Introduction of a donor exposure reduction programme for multiple-transfused very-low-birth-weight infants.
Kirsten GF; Kirsten CL; Faber M; Collett C; Mitchell CA; Bird AR
S Afr Med J; 1996 Nov; 86(11 Suppl):1460-4. PubMed ID: 9180796
[TBL] [Abstract][Full Text] [Related]
7. Estimating blood needs for very-low-birth-weight infants.
Fabres J; Wehrli G; Marques MB; Phillips V; Dimmitt RA; Westfall AO; Schelonka RL
Transfusion; 2006 Nov; 46(11):1915-20. PubMed ID: 17076846
[TBL] [Abstract][Full Text] [Related]
8. [Blood sampling and transfusion therapy in the preterm infant].
Rodríguez Fernández A; Solís Sánchez G; Ballesteros García S; Llaneza Ruiz J; Lagunilla Herrero L; Pérez Méndez C
An Esp Pediatr; 1998 Jul; 49(1):55-9. PubMed ID: 9718768
[TBL] [Abstract][Full Text] [Related]
9. [Anemia of prematurity: risk factors influencing red cell transfusions].
Zuppa AA; Mazzotta M; Maragliano G; Girlando P; Florio MG; Tortorolo G
Minerva Pediatr; 1995; 47(1-2):13-8. PubMed ID: 7791703
[TBL] [Abstract][Full Text] [Related]
10. Use of red blood cells older than five days for neonatal transfusion.
Patten E; Robbins M; Vincent J; Richardson J; Hokanson J
J Perinatol; 1991 Mar; 11(1):37-40. PubMed ID: 2037888
[TBL] [Abstract][Full Text] [Related]
11. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants.
Kirpalani H; Whyte RK; Andersen C; Asztalos EV; Heddle N; Blajchman MA; Peliowski A; Rios A; LaCorte M; Connelly R; Barrington K; Roberts RS
J Pediatr; 2006 Sep; 149(3):301-307. PubMed ID: 16939737
[TBL] [Abstract][Full Text] [Related]
12. [Blood product transfusion in the neonatal period].
Arnaud F; Simeoni U
Transfus Clin Biol; 2005 Oct; 12(4):336-41. PubMed ID: 16169272
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the approach to anemia in the preterm infant: is there a role for erythropoietin therapy?
Asch J; Wedgwood JF
J Perinatol; 1997; 17(4):276-82. PubMed ID: 9280091
[TBL] [Abstract][Full Text] [Related]
14. The age of red blood cells in premature infants (ARIPI) randomized controlled trial: study design.
Fergusson D; Hutton B; Hogan DL; LeBel L; Blajchman MA; Ford JC; Hebert P; Kakadekar A; Kovacs L; Lee S; Sankaran K; Shapiro S; Smyth JA; Ramesh K; Bouali NR; Tinmouth A; Walker R
Transfus Med Rev; 2009 Jan; 23(1):55-61. PubMed ID: 19056034
[TBL] [Abstract][Full Text] [Related]
15. Reduction of donor exposures in premature infants by the use of designated adenine-saline preserved split red blood cell packs.
Mangel J; Goldman M; Garcia C; Spurll G
J Perinatol; 2001 Sep; 21(6):363-7. PubMed ID: 11593369
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the practice of transfusion in the anemia in preterm infants].
Elguazzar S; Alaoui AM; Izgua AT
Rev Med Brux; 2013; 34(1):4-11. PubMed ID: 23534309
[TBL] [Abstract][Full Text] [Related]
17. A comparative cohort study on transfusion practice and outcome in two Dutch tertiary neonatal centres.
Khodabux CM; Hack KE; von Lindern JS; Brouwers H; Walther FJ; Brand A
Transfus Med; 2009 Aug; 19(4):195-201. PubMed ID: 19706136
[TBL] [Abstract][Full Text] [Related]
18. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
20. Splanchnic-cerebral oxygenation ratio as a marker of preterm infant blood transfusion needs.
Bailey SM; Hendricks-Muñoz KD; Mally P
Transfusion; 2012 Feb; 52(2):252-60. PubMed ID: 21790634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
